Title : K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.

Pub. Date : 2012 Nov

PMID : 22909976






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
2 Multivariate analysis revealed a predictive significance for K-Ras mutations with respect to time to progression in patients treated with irinotecan and oxaliplatin as first-line chemotherapy. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
3 Also, K-Ras mutation status may predict time to progression in patients treated with irinotecan and oxaliplatin. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens